| mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
3e-06 |
| mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
3e-06 |
| mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
3e-06 |
| mRNA |
Doxorubicin |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
3e-06 |
| mRNA |
CP466722 |
GDSC1000 |
pan-cancer |
AAC |
0.14 |
3e-06 |
| mRNA |
methylstat |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
3e-06 |
| mRNA |
GSK-J4 |
CTRPv2 |
pan-cancer |
AAC |
0.47 |
4e-06 |
| mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.18 |
4e-06 |
| mRNA |
SB-525334 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
4e-06 |
| mRNA |
tipifarnib |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
4e-06 |